Agro-Biotech News
Wednesday, 13-05-2026 | 08:37
Pairwise, a global leader in precision breeding, has announced a major commercial licensing agreement with CSIRO, Australia's national science agency. This partnership grants CSIRO access to the Fulcrum® platform, a sophisticated suite of CRISPR-based gene editing tools, including the proprietary SHARC™ enzyme. The agreement marks one of the most comprehensive licenses issued by Pairwise to date, spanning applications across plants, livestock, aquaculture, and microbes.



